Isopropyl Alcohol

Isopropyl Alcohol

SCHEMBL6561632

CC(C)O.CC(N)(CO)CO

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
HIF1A Q16665 1/20 0.32
MAPK1 P28482 1/20 0.32
TSHR P16473 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23687 0.87
SCHEMBL1252882 0.86 TDP1 (0.38) LMNAALDH1A1MEN1KMT2ATDP1
Hydroxyamine SCHEMBL7977355 0.83
Ammonia Solution, Strong SCHEMBL30925320 0.83
Fluoride SCHEMBL11309264 0.83
Hydrochloric Acid SCHEMBL8764642 0.83 MEN1 (0.44) LMNAMEN1KMT2A
Hydrochloric Acid SCHEMBL78515 0.83
Water SCHEMBL5889074 0.83
Deanol SCHEMBL3455341 0.80 MEN1 (0.41) LMNAMEN1KMT2A
SCHEMBL28295727 0.78 GABRR1 (0.41) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1137391-B1 METHOD FOR TREATING HAIR NOVOZYMES AS (DK) 2004-11-03 EP disclosed
US-6572843-B1 Combining permanent dyeing and straightening; applying to reduced hair an oxidizing enzyme (Laccase), a mediator, and a chemical oxidizing agent that produces hydrogen peroxide NOVOZYMES, A/S (DK) 2003-06-03 US disclosed
EP-1076494-B1 RE-FORMATION OF KERATINOUS FIBRE CROSS LINKS NOVOZYMES AS (DK) 2002-09-18 EP disclosed
US-20020007524-A1 Contacting fibers in a dry state with an oxidoreductase and a dye precursor; reduced hair damage NOVOZYMES A/S (DK) 2002-01-24 US disclosed
EP-1137391-A1 METHOD FOR TREATING HAIR Novozymes A/S (DK) 2001-10-04 EP disclosed
EP-1014921-A1 ENZYMATIC FOAM COMPOSITIONS FOR DYEING KERATINOUS FIBRES NOVO NORDISK A/S (DK) 2000-07-05 EP disclosed
WO-2000032158-A1 METHOD FOR TREATING HAIR NOVOZYMES A/S (DK) 2000-06-08 WO disclosed
US-5899212-A CLEAVAGE OF DISULFIDE BONDS, OXIDOREDUCTASE NOVO NORDISK A/S (DK) 1999-05-04 US disclosed
WO-1999015137-A1 ENZYMATIC FOAM COMPOSITIONS FOR DYEING KERATINOUS FIBRES NOVO NORDISK A/S (DK) 1999-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020007524-A1 Contacting fibers in a dry state with an oxidoreductase and a dye precursor; reduced hair damage KRT18, CYB5R3, ADH7 LMNA 2638/4885ALDH1A1 169/4885MEN1 4857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.